Post by International Society of Aesthetic Plastic Surgery - ISAPS

5,407 followers

GLP-1 medications are changing the landscape of medicine. But are plastic surgeons fully aware of their implications for patient safety? In this important update, ISAPS Patient Safety Committee Chair, Dr. André Cervantes, explores how medications such as semaglutide and tirzepatide are influencing perioperative management in aesthetic surgery. From anesthesia considerations and aspiration risk to the effects of rapid weight loss on tissue quality, healing, and surgical outcomes, this video highlights key factors every plastic surgeon should keep in mind when treating patients using GLP-1 therapies. 🎥 Watch now to stay up to date on this evolving topic and learn how to optimize patient safety through careful assessment, planning, and multidisciplinary collaboration. For more information, please read our latest Patient Safety Statement on Weight Loss Drugs: https://lnkd.in/dEvR7TvK.

Post content

Video Content